Europa Bioproducts Ltd is the European Distributor for ProZyme Inc.
ProZyme is a U.S. manufacturer of speciality proteins & enzymes for diagnostic and research applications. In January 2003 ProZyme purchased the GlykoTM line of enzymes for glycobiology, reagents and product for carbohydrate analysis from Biomarin pharmaceutical Inc.
ProZyme is now the only licensed manufacturer of FACETM reagents ( including N-GlycanaseTM recombinant PNGase F) used by pharmaceutical companies for the characterisation of glycans for QC release of therapeutic proteins, and is fast becoming "The worlds premier supplier of Glycobiology products".
Please find BioMarin's announcement letter concerning ProZyme's purchase of Glyko at:
http://www.prozyme.com/pdf/glyko010303.pdf
The Glyko product range includes a very comprehensive list of deglycosylation enzymes, cleanup cartridges, HPLC columns, carbohydrate standards and convenient kits for analysis of glycoproteins.
ProZyme's goal is to manufacture all the major components in-house. This ensures the highest quality product, produced consistently and available from stock. ProZyme welcomes its customers to audit these processes. Minor components which are not manufactured by ProZyme are sourced from reliable companies, tested by ProZyme before being included into the manufacturing of kits.
We encourage researchers throughout Europe to browse our website where you can find technical information, minimum quantity pricing, place orders and make secure payments by credit card or normal credit terms of 30 days.
Additional Glyko technical data and Material Safety Data Sheets, in Adobe® Acrobat ® format, are available at the Prozyme site. Clicking below will take you to the Glyko PDF index page.
http://www.glyko.com
Contact us for more information about ProZyme or the Glyko line of enzymes for glycobiology.
*Glyko and FACE are registered trademarks of ProZyme, Inc, San Leandro, CA, USA.
*N-Glycanase® is a registered trademark of Genzyme Corporation, Boston, MA, USA. Recombinant PNGase F is covered by US Patent No 5,238,821, which is exclusively licensed for manufacture by ProZyme, Inc.